FR2323440A1 - Distributeur fonctionnant par osmose et son procede de fabrication - Google Patents

Distributeur fonctionnant par osmose et son procede de fabrication

Info

Publication number
FR2323440A1
FR2323440A1 FR7627262A FR7627262A FR2323440A1 FR 2323440 A1 FR2323440 A1 FR 2323440A1 FR 7627262 A FR7627262 A FR 7627262A FR 7627262 A FR7627262 A FR 7627262A FR 2323440 A1 FR2323440 A1 FR 2323440A1
Authority
FR
France
Prior art keywords
osmosis
manufacturing process
distributor operating
distributor
operating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7627262A
Other languages
English (en)
Other versions
FR2323440B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of FR2323440A1 publication Critical patent/FR2323440A1/fr
Application granted granted Critical
Publication of FR2323440B1 publication Critical patent/FR2323440B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Feeding, Discharge, Calcimining, Fusing, And Gas-Generation Devices (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Detergent Compositions (AREA)
FR7627262A 1975-09-11 1976-09-10 Distributeur fonctionnant par osmose et son procede de fabrication Granted FR2323440A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/612,465 US4036228A (en) 1975-09-11 1975-09-11 Osmotic dispenser with gas generating means

Publications (2)

Publication Number Publication Date
FR2323440A1 true FR2323440A1 (fr) 1977-04-08
FR2323440B1 FR2323440B1 (fr) 1978-05-05

Family

ID=24453276

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7627262A Granted FR2323440A1 (fr) 1975-09-11 1976-09-10 Distributeur fonctionnant par osmose et son procede de fabrication

Country Status (12)

Country Link
US (1) US4036228A (fr)
JP (1) JPS6035169B2 (fr)
AU (1) AU500443B2 (fr)
CA (1) CA1047874A (fr)
CH (1) CH620121A5 (fr)
DE (1) DE2640904A1 (fr)
FR (1) FR2323440A1 (fr)
GB (1) GB1516442A (fr)
IE (1) IE44451B1 (fr)
IT (1) IT1068749B (fr)
MX (1) MX146684A (fr)
SE (1) SE429101B (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480616A1 (fr) * 1979-02-12 1981-10-23 Alza Corp Dispositif pour l'apport de substances par diffusion a un milieu environnant
EP0040899A2 (fr) * 1980-04-25 1981-12-02 Alza Corporation Méthode de libération d'une substance active grâce à l'activité effervescente engendrée dans le milieu d'utilisation
EP0088394A2 (fr) * 1982-03-05 1983-09-14 Eisai Co., Ltd. Composition stable effervescente pour suppositoire vaginal et suppositoires fabriqués à l'aide de cette composition
FR2555897A1 (fr) * 1983-12-01 1985-06-07 Alza Corp Systeme d'apport, a debit constant et a liberation pulsee, de substances a un milieu environnant
FR2586190A1 (fr) * 1985-08-16 1987-02-20 Alza Corp Dispositif d'apport pour delivrer une composition d'agent profitable a un milieu d'utilisation
WO2000025742A1 (fr) * 1998-10-30 2000-05-11 Lts Lohmann Therapie-Systeme Ag Systeme therapeutique gonflant de retention stomacale a temps de sejour prolonge dans l'estomac

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4203439A (en) * 1976-11-22 1980-05-20 Alza Corporation Osmotic system with volume amplifier for increasing amount of agent delivered therefrom
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4101650A (en) * 1977-04-06 1978-07-18 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Pepstatin floating minicapsules
US4203441A (en) * 1978-12-18 1980-05-20 Alza Corporation Osmotically triggered device with gas generating means
US4344929A (en) * 1980-04-25 1982-08-17 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4278087A (en) * 1980-04-28 1981-07-14 Alza Corporation Device with integrated operations for controlling release of agent
IE54171B1 (en) * 1982-06-22 1989-07-05 Univ Glasgow Device for introducing nutrients and/or therapeutic materials into ruminant animals
US4522625A (en) * 1982-09-29 1985-06-11 Alza Corporation Drug dispenser comprising wall formed of semipermeable member and enteric member
US4476115A (en) * 1983-07-05 1984-10-09 Reed Raymond E Analgesic composition and method of treating subdermal pain
US4732915A (en) * 1983-11-02 1988-03-22 Alza Corporation Process for increasing solubility of drug
US4610686A (en) * 1983-11-02 1986-09-09 Alza Corporation Controlled delivery of haloperidol by an osmotic delivery system
US4663147A (en) * 1985-09-03 1987-05-05 International Minerals & Chemical Corp. Disc-like sustained release formulation
DE3611812A1 (de) * 1986-04-08 1987-10-15 Mueller Franz Vorrichtung zur abgabe von aktivem mittel
US4847093A (en) * 1986-06-19 1989-07-11 Alza Corporation Dosage form with means for governing rate of gas formation
DE3627475A1 (de) * 1986-06-26 1988-01-14 Gergely Gerhard Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
JPH0678247B2 (ja) * 1988-10-04 1994-10-05 大塚製薬株式会社 Ｎｍｒ造影用鉄含有製剤
NZ232346A (en) * 1989-02-07 1992-03-26 Duphar Int Res Effervescent oral rehydration solution comprising saccharides, amino acids and bicarbonate salts
US5019396A (en) * 1989-05-12 1991-05-28 Alza Corporation Delivery dispenser for treating cardiac arrhythmias
US5127945A (en) * 1990-09-28 1992-07-07 The United States Of America As Represented By The Secretary Of The Navy Effervescent cationic film forming corrosion inhibitor material for use in torpedo launcher tubes
US5151093A (en) * 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
JPH07127586A (ja) * 1993-11-05 1995-05-16 Kobe Steel Ltd スクリュ圧縮機
US5540665A (en) * 1994-01-31 1996-07-30 Alza Corporation Gas driven dispensing device and gas generating engine therefor
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
IE70735B1 (en) * 1994-08-15 1996-12-11 Elan Med Tech Orally administrable delivery device
JP3239217B2 (ja) * 1994-09-10 2001-12-17 トローク，ベルント・シィエイチ 水濾過
AU2059297A (en) * 1996-03-12 1997-10-01 Alza Corporation Composition and dosage form comprising opioid antagonist
US5945099A (en) * 1996-09-26 1999-08-31 Marshall; Lucia G. I. Mycoherbicidal delivery compositions, preparation and methods for controlling aquatic weeds
US5888500A (en) * 1996-09-26 1999-03-30 Marshall; Lucia G. I. Biological control agent biocarriers and method of formation
JP4863534B2 (ja) * 1996-10-25 2012-01-25 スパーナス ファーマシューティカルズ インコーポレイテッド 可溶形態浸透用量送達システム
US6361796B1 (en) 1996-10-25 2002-03-26 Shire Laboratories, Inc. Soluble form osmotic dose delivery system
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
IN186245B (fr) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US7890176B2 (en) * 1998-07-06 2011-02-15 Boston Scientific Neuromodulation Corporation Methods and systems for treating chronic pelvic pain
GB2341798B (en) * 1998-09-25 2001-03-14 Brian Whittle Associates Ltd Nutritional and pharmaceutical compositions comprising desiccants
US6541021B1 (en) 1999-03-18 2003-04-01 Durect Corporation Devices and methods for pain management
US6835194B2 (en) * 1999-03-18 2004-12-28 Durect Corporation Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
JP4428899B2 (ja) * 1999-07-02 2010-03-10 エルテーエス ローマン テラピー−ジステーメ アーゲー ポリシロキサンおよび両親和性溶媒を基にした微小貯蔵所系
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
US6582441B1 (en) 2000-02-24 2003-06-24 Advanced Bionics Corporation Surgical insertion tool
US7074803B2 (en) * 2001-03-02 2006-07-11 Durect Corporation Opioid formulations
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
KR20030061392A (ko) 2000-11-03 2003-07-18 안드렉스 코포레이션 방출 조절성 메트포민 조성물
US6790459B1 (en) 2000-11-03 2004-09-14 Andrx Labs, Llc Methods for treating diabetes via administration of controlled release metformin
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
US20050070883A1 (en) * 2000-11-29 2005-03-31 Brown James E Devices and methods for controlled delivery from a drug delivery device
US6544557B2 (en) * 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US20060064140A1 (en) * 2001-01-30 2006-03-23 Whitehurst Todd K Methods and systems for stimulating a trigeminal nerve to treat a psychiatric disorder
US7493172B2 (en) * 2001-01-30 2009-02-17 Boston Scientific Neuromodulation Corp. Methods and systems for stimulating a nerve originating in an upper cervical spine area to treat a medical condition
US20050143789A1 (en) * 2001-01-30 2005-06-30 Whitehurst Todd K. Methods and systems for stimulating a peripheral nerve to treat chronic pain
EP1379197A4 (fr) * 2001-03-23 2009-06-03 Durect Corp Administration de medicaments au moyen de dispositifs a liberation lente implantes dans un tissu myocardique ou dans la cavite pericardique
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
UA81224C2 (uk) 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US20030175346A1 (en) * 2002-02-01 2003-09-18 Anne Billotte Osmotic delivery system
US20030161882A1 (en) * 2002-02-01 2003-08-28 Waterman Kenneth C. Osmotic delivery system
DE60219965T2 (de) * 2002-04-23 2008-01-17 Lupin Ltd., Mumbai Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
AU2003241537A1 (en) * 2002-05-23 2003-12-12 Andrx Corporation Biguanide formulations
US7151961B1 (en) * 2002-05-24 2006-12-19 Advanced Bionics Corporation Treatment of movement disorders by brain stimulation
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US7254449B2 (en) * 2002-07-31 2007-08-07 Advanced Bionics Corp Systems and methods for providing power to one or more implantable devices
US6797235B2 (en) * 2002-09-05 2004-09-28 Co2 Technologies, Inc. Device and methods for modifying an atmosphere
AU2002331830A1 (en) 2002-09-06 2004-03-29 Durect Corporation Delivery of modulators of glutamate-mediated neurotransmission to the inner ear
US20060009739A1 (en) * 2002-09-06 2006-01-12 Durect Corporation Implantable flow regulator with failsafe mode and reserve drug supply
US20050048119A1 (en) * 2002-09-20 2005-03-03 Avinash Nangia Controlled release composition with semi-permeable membrane and poloxamer flux enhancer
EP1551372B8 (fr) 2002-09-20 2018-08-01 Alpharma Pharmaceuticals LLC Sous-unite de sequestration et compositions et procedes associes
EP2604266A1 (fr) 2002-09-20 2013-06-19 Andrx Labs Llc Nouvelle formulation pharmaceutique contenant un biguanide et dérivé de thiazolidinedione
US20050051922A1 (en) * 2002-09-20 2005-03-10 Avinash Nangia Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
US20070083240A1 (en) * 2003-05-08 2007-04-12 Peterson David K L Methods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulator
JP2007525188A (ja) 2003-05-16 2007-09-06 インターミューン インコーポレイテッド 合成ケモカイン受容体リガンドおよびその使用方法
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
WO2005040758A2 (fr) * 2003-10-24 2005-05-06 Intermune, Inc. Utilisation de pirfenidone dans des posologies therapeutiques
US20050095288A1 (en) * 2003-11-03 2005-05-05 Andrx Labs, Llc Decongestant and expectorant tablets
WO2005062829A2 (fr) * 2003-12-19 2005-07-14 Advanced Bionics Corporation Systeme de stimulation electrique monte sur le crane et methode de traitement de patients
US20060233922A1 (en) * 2004-05-28 2006-10-19 Andrew Kegler Packaged flavor enhanced fruits or vegetables products with extended shelf-life for mass market distribution and consumption
US20050267555A1 (en) * 2004-05-28 2005-12-01 Marnfeldt Goran N Engagement tool for implantable medical devices
US7713550B2 (en) * 2004-06-15 2010-05-11 Andrx Corporation Controlled release sodium valproate formulation
US20050276848A1 (en) * 2004-06-15 2005-12-15 Nilobon Podhipleux Sustained release neutralized divalproex sodium
US20050287185A1 (en) * 2004-06-23 2005-12-29 David Wong Extended release oxybutynin formulation
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
WO2006010013A1 (fr) * 2004-07-09 2006-01-26 Advanced Bionics Corporation Systemes et procedes d'utilisation d'une bobine papillon afin de communiquer avec un dispositif medical implantable ou de transferer de la puissance dans un tel dispositif
US8452407B2 (en) 2004-08-16 2013-05-28 Boston Scientific Neuromodulation Corporation Methods for treating gastrointestinal disorders
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8268791B2 (en) 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
EP1789075A4 (fr) 2004-08-25 2009-07-01 Uab Research Foundation Substances ameliorant l'absorption destinees a l'administration de medicaments
US9358393B1 (en) 2004-11-09 2016-06-07 Andres M. Lozano Stimulation methods and systems for treating an auditory dysfunction
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
US7483746B2 (en) * 2004-12-06 2009-01-27 Boston Scientific Neuromodulation Corp. Stimulation of the stomach in response to sensed parameters to treat obesity
US9327069B2 (en) 2004-12-21 2016-05-03 Boston Scientific Neuromodulation Corporation Methods and systems for treating a medical condition by promoting neural remodeling within the brain
US9095713B2 (en) * 2004-12-21 2015-08-04 Allison M. Foster Methods and systems for treating autism by decreasing neural activity within the brain
US20060161217A1 (en) * 2004-12-21 2006-07-20 Jaax Kristen N Methods and systems for treating obesity
US20070038264A1 (en) * 2004-12-21 2007-02-15 Jaax Kristen N Methods and systems for treating autism
US9352145B2 (en) * 2004-12-22 2016-05-31 Boston Scientific Neuromodulation Corporation Methods and systems for treating a psychotic disorder
US8515541B1 (en) 2004-12-22 2013-08-20 Boston Scientific Neuromodulation Corporation Methods and systems for treating post-stroke disorders
US20060185665A1 (en) * 2005-02-22 2006-08-24 Bachinski Thomas J Sauna fireplace
US20060194724A1 (en) * 2005-02-25 2006-08-31 Whitehurst Todd K Methods and systems for nerve regeneration
US7702385B2 (en) * 2005-11-16 2010-04-20 Boston Scientific Neuromodulation Corporation Electrode contact configurations for an implantable stimulator
US7848803B1 (en) 2005-03-14 2010-12-07 Boston Scientific Neuromodulation Corporation Methods and systems for facilitating stimulation of one or more stimulation sites
US8423155B1 (en) 2005-03-14 2013-04-16 Boston Scientific Neuromodulation Corporation Methods and systems for facilitating stimulation of one or more stimulation sites
US7853321B2 (en) * 2005-03-14 2010-12-14 Boston Scientific Neuromodulation Corporation Stimulation of a stimulation site within the neck or head
US7684858B2 (en) * 2005-09-21 2010-03-23 Boston Scientific Neuromodulation Corporation Methods and systems for placing an implanted stimulator for stimulating tissue
EP1948246B1 (fr) * 2005-11-14 2017-05-03 Theragene Pharmaceuticals, Inc. Thérapie par facteur de cellules souches pour lésion tissulaire
US7729758B2 (en) * 2005-11-30 2010-06-01 Boston Scientific Neuromodulation Corporation Magnetically coupled microstimulators
US7982066B2 (en) * 2005-12-09 2011-07-19 Novalife, Inc. High protein supplement
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US7610100B2 (en) * 2005-12-30 2009-10-27 Boston Scientific Neuromodulation Corporation Methods and systems for treating osteoarthritis
US7835803B1 (en) * 2006-01-17 2010-11-16 Boston Scientific Neuromodulation Corporation Lead assemblies with one or more switching networks
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
US8175710B2 (en) * 2006-03-14 2012-05-08 Boston Scientific Neuromodulation Corporation Stimulator system with electrode array and the method of making the same
US7777641B2 (en) * 2006-03-29 2010-08-17 Advanced Bionics, Llc Systems and methods of facilitating communication between a first and second device
WO2007112581A1 (fr) 2006-04-03 2007-10-11 Isa Odidi Dispositif d'administration à libération commandée comprenant un enrobage organosol
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US20070292568A1 (en) * 2006-06-14 2007-12-20 Kaufman Galen D Dynamic modified atmosphere package system
EP2526932B1 (fr) 2006-06-19 2017-06-07 Alpharma Pharmaceuticals LLC Composition pharmaceutique
US8504163B1 (en) 2006-06-30 2013-08-06 Boston Scientific Neuromodulation Corporation Cranially mounted stimulation systems and methods
US8401654B1 (en) 2006-06-30 2013-03-19 Boston Scientific Neuromodulation Corporation Methods and systems for treating one or more effects of deafferentation
WO2008063727A2 (fr) * 2006-08-21 2008-05-29 United Therapeutics Corporation Polytherapie destinée a traiter des infections virales
US7445528B1 (en) 2006-09-29 2008-11-04 Boston Scientific Neuromodulation Corporation Connector assemblies
US7347746B1 (en) 2006-10-27 2008-03-25 Boston Scientific Neuromodulation Corporation Receptacle connector assembly
US20080064701A1 (en) * 2007-04-24 2008-03-13 Ramesh Sesha Anti-diabetic combinations
US20070172525A1 (en) * 2007-03-15 2007-07-26 Ramesh Sesha Anti-diabetic combinations
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US8551524B2 (en) * 2008-03-14 2013-10-08 Iycus, Llc Anti-diabetic combinations
WO2010011232A1 (fr) * 2008-07-24 2010-01-28 Handa Pharmaceuticals, Llc Formulation antipsychotique atypique stabilisée
WO2010039801A2 (fr) 2008-10-02 2010-04-08 The J. David Gladstone Institutes Méthodes de traitement d’une infection par le virus de l’hépatite c
EP2408449A4 (fr) 2009-03-18 2012-08-08 Univ Leland Stanford Junior Méthodes et compositions pour traiter l'infection par un virus de la famille des flaviviridae
WO2011079074A1 (fr) * 2009-12-24 2011-06-30 Acura Phamaceuticals, Inc. Compositions pharmaceutiques pour prévenir un mauvaise usage, un usage abusif et un usage détourné
EP2340814A3 (fr) * 2009-12-31 2012-05-23 Ranbaxy Laboratories Limited Comprimé d'aspirine stable et son procédé de préparation
WO2012175698A1 (fr) 2011-06-23 2012-12-27 Université Libre de Bruxelles Utilisation thérapeutique d'acide rétinoïque all-trans (atra) chez des patients souffrant de la maladie alcoolique du foie
JP2014527801A (ja) 2011-09-01 2014-10-23 ユニバーシティ オブ サザン カリフォルニア ハイスループットペプチドミメティックを調製するための方法、経口バイオアベイラブルな薬物およびそれを含有する組成物
CN104066432B (zh) 2011-12-06 2017-06-13 小利兰·斯坦福大学董事会 用于治疗病毒性疾病的方法和组合物
CA2910865C (fr) 2014-07-15 2016-11-29 Isa Odidi Compositions et methodes destines a reduire les surdoses
WO2016132218A1 (fr) 2015-02-20 2016-08-25 Osmotica Kereskedelmi Es Szolgaltato Kft Méthode d'administration de r-baclofène dans une forme pharmaceutique à libération prolongée
CA2993009A1 (fr) 2015-07-31 2017-02-09 Research Institute At Nationwide Children's Hospital Peptides et anticorps pour l'elimination de biofilms
WO2017066719A2 (fr) 2015-10-14 2017-04-20 Research Institute At Nationwide Children's Hospital Agents spécifiques interférant avec hu
JP7514621B2 (ja) 2017-01-04 2024-07-11 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル Ｄｎａｂｉｉワクチンおよび強化された活性を有する抗体
AU2018206560A1 (en) 2017-01-04 2019-07-18 Research Institute At Nationwide Children's Hospital Antibody fragments for the treatment of biofilm-related disorders
EP4361171A2 (fr) 2019-07-08 2024-05-01 Research Institute at Nationwide Children's Hospital Compositions d'anticorps pour la rupture de biofilms

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE676458A (fr) * 1965-02-15 1966-06-16
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US536155A (en) * 1895-03-19 Pill or tablet
US1356544A (en) * 1918-01-29 1920-10-26 P M Miller Hygienic Specialty Medicinal effervescing capsule
US1707762A (en) * 1926-02-05 1929-04-02 John G Homan Medical capsule
US3604417A (en) * 1970-03-31 1971-09-14 Wayne Henry Linkenheimer Osmotic fluid reservoir for osmotically activated long-term continuous injector device
US3760984A (en) * 1971-09-29 1973-09-25 Alza Corp Osmotically powered agent dispensing device with filling means
US3756236A (en) * 1972-03-02 1973-09-04 J Murray Hygenic douche system
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE676458A (fr) * 1965-02-15 1966-06-16
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480616A1 (fr) * 1979-02-12 1981-10-23 Alza Corp Dispositif pour l'apport de substances par diffusion a un milieu environnant
EP0040899A2 (fr) * 1980-04-25 1981-12-02 Alza Corporation Méthode de libération d'une substance active grâce à l'activité effervescente engendrée dans le milieu d'utilisation
EP0040899A3 (en) * 1980-04-25 1982-08-11 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
EP0088394A2 (fr) * 1982-03-05 1983-09-14 Eisai Co., Ltd. Composition stable effervescente pour suppositoire vaginal et suppositoires fabriqués à l'aide de cette composition
EP0088394A3 (en) * 1982-03-05 1983-10-12 Eisai Co., Ltd. Stable, effervescent vaginal suppository composition and suppositories made therefrom
FR2555897A1 (fr) * 1983-12-01 1985-06-07 Alza Corp Systeme d'apport, a debit constant et a liberation pulsee, de substances a un milieu environnant
FR2586190A1 (fr) * 1985-08-16 1987-02-20 Alza Corp Dispositif d'apport pour delivrer une composition d'agent profitable a un milieu d'utilisation
WO2000025742A1 (fr) * 1998-10-30 2000-05-11 Lts Lohmann Therapie-Systeme Ag Systeme therapeutique gonflant de retention stomacale a temps de sejour prolonge dans l'estomac
US6776999B1 (en) 1998-10-30 2004-08-17 Lts Lohmann Therapie-Systeme Ag Expandable gastroretentive therapeutical system with prolonged stomach retention time

Also Published As

Publication number Publication date
AU500443B2 (en) 1979-05-24
IT1068749B (it) 1985-03-21
IE44451B1 (en) 1981-12-02
FR2323440B1 (fr) 1978-05-05
US4036228A (en) 1977-07-19
JPS5233886A (en) 1977-03-15
AU1706976A (en) 1978-03-02
SE429101B (sv) 1983-08-15
DE2640904C2 (fr) 1989-01-26
MX146684A (es) 1982-07-28
CH620121A5 (fr) 1980-11-14
JPS6035169B2 (ja) 1985-08-13
CA1047874A (fr) 1979-02-06
DE2640904A1 (de) 1977-03-24
SE7609405L (sv) 1977-03-12
GB1516442A (en) 1978-07-05
IE44451L (en) 1977-03-11

Similar Documents

Publication Publication Date Title
FR2323440A1 (fr) Distributeur fonctionnant par osmose et son procede de fabrication
FR2302052A1 (fr) Procede de fabri
FR2324338A1 (fr) Membrane semi-permeable et son procede de fabrication
FR2301605A1 (fr) Procede de production
FR2298596A1 (fr) Procede de fa
FR2301555A1 (fr) Procede de r
FR2307833A1 (fr) Procede de preparation de polyphenylene-ethers
FR2300105A1 (fr) Procede de fabrication de panneaux en f
FR2297574A1 (fr) Procede de fabrication de sucreries
BE840540A (fr) Procede de preparation de sterol-glycosides aisement absorbables
FR2302048A1 (fr) Procede de traitement de ma
FR2297921A1 (fr) Procede de r
BE838893A (fr) Procede de fabrication de cyclohexanonexime
FR2300584A1 (fr) Procede de fabri
FR2327987A1 (fr) Procede de preparation de 4-alkyl-thiosemicarbazides
FR2325657A1 (fr) Procede de fabrication de chlorophosphites
BE813390A (fr) Procede de fabrication de nitro-2-halogenophenols
FR2311011A1 (fr) Procede de fabrication de 2-aryl-2h-benzotriazoles
FR2299963A1 (fr) Procede de fabrication d
BE839291A (fr) Procede de preparation de 4-acylaminocanthrones
BE846563A (fr) Procede de preparation de 2-oxo-oxazolidines
BE845980A (fr) Procede de preparation de polypropylene-polyamines
FR2316890A1 (fr) Procede de fabrication en continu de coiffes
BE845696A (fr) Procede de dopage de barreaux semi-conducteurs
BE848698A (fr) Procede perfectionne de fabrication du m-chlorocarbanilate de 4-chloro-2-butynyle,

Legal Events

Date Code Title Description
ST Notification of lapse